Early Risk Stratification of Dosing Errors in Clinical Trials Using Machine Learning
Félicien Hêche, Sohrab Ferdowsi, Anthony Yazdani, Sara Sansaloni-Pastor, Douglas Teodoro · 2026
Read Early Risk Stratification of Dosing Errors in Clinical Trials Using Machine Learning by Félicien Hêche, Sohrab Ferdowsi, Anthony Yazdani, Sara Sansaloni-Pastor, Douglas Teodoro (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2602-22285.txt.
Description
Dosing errors in clinical trials endanger patients, yet trials at high risk are usually spotted only after errors accumulate. Félicien Hêche and four co-authors build a machine-learning framework that stratifies trials by dosing-error risk before they start, using only information available at initiation. Their dataset spans over forty-two thousand trials from a public registry, with structured, semi-structured, and free-text protocol data.
Labels marking elevated dosing-error rates come from adverse-event reports, medical terminology, and confidence intervals. Three models are tested, and a late-fusion model combining structured and textual signals achieves the strongest discrimination, with calibrated probabilities for interpretable trial-level risk. Trial overseers gain an early-warning tool for steering monitoring where it matters most.
Catalog record
| CREATOR | Félicien Hêche, Sohrab Ferdowsi, Anthony Yazdani, Sara Sansaloni-Pastor, Douglas Teodoro |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 45 KB |
| VERSION | 1.0 |
| LICENSE | http://creativecommons.org/licenses/by/4.0/ |
| RIGHTS | CC BY |
| SOURCE | arXiv |
Source: https://arxiv.org/abs/2602-22285